Covovax trials begin in India, hope to launch it by Sept 2021: Adar Poonawalla

​​In August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3u04o4E
via IFTTT